1 |
BIO, Biomedtracker, AMPLION. Clinical Development Success Rates 2006-2015. In: BIO Industry Analysis. Available from: https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf.
|
2 |
Jung S-Y, Choi N-K, Lee J, Park B-J. Use of big data for drug safety monitoring and decision making. J Korean Med Assoc. 2014;57(5):391-7.
DOI
|
3 |
Alomar MJ, Factors affecting the development of adverse drug reactions. Saudi Pharma J. 2014;22(2):83-94.
DOI
|
4 |
Uppsala Monitoring Center. UMC Web page. [cited 2020 12 Jan]; Available from: https://www.who-umc.org/.
|
5 |
Park B-J. Status and Improvement Plan of Patient Safety Management System Related to Pharmaceutical Products. HIRA Policy Trend. 2014;8(5):16-26.
|
6 |
Park J-W. Past, Present, and Future of Korean Regional Drug Safety Center. JPERM. 2018;10:43-8.
|
7 |
Ploen M. Signal Detection in a Global Database. 2018 [cited 2020 12 Jan]; Available from: https://www.meddra.org/sites/default/files/page/documents_insert/signal_detection_in_a_global_database.pdf.
|
8 |
APEC Harmonization Center. 2015 AHC Activity Report. 2016:28-31.
|
9 |
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2): 77-101.
DOI
|
10 |
Woo Y-j, Chung S-y, Park B-J. Current Status of Spontaneous Adverse Reactions Reporting System on Herbal Medicine in China, Japan, Korea and WHO. J Int Korean Med. 2014;35(2):111-8.
|
11 |
Woo Y-j, Chung S-y, Park B-J. Necessity of Reporting on Herbal Medicine Adverse Event and Introduction of Reporting Method. J Int Korean Med. 2014;Oct:174-9.
|
12 |
Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140(3): 513-8.
DOI
|
13 |
Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19-31.
DOI
|
14 |
Shetti S, Kumar CD, Sriwastava NK, Sharma IP. Pharmacovigilance of herbal medicines: Current state and future directions. Pharmacogn Mag. 2011;7(25):69-73.
DOI
|
15 |
Inman WH. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41(5):434-5.
DOI
|
16 |
Hartman J, Harmark L, van Puijenbroek E. A global view of undergraduate education in pharmacovigilance. Eur J Clin Pharmacol. 2017;73(7):891-9.
DOI
|
17 |
Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37(10):743-59.
DOI
|
18 |
van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, et al. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf. 2018;41(11):1003-11.
DOI
|
19 |
Lareb. Pharmacovigilance Education for Universities. 2017; Available from: https://www.pv-education.org.
|
20 |
Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rolfes L, van Puijenbroek EP, et al. Feasibility and educational value of a student-run pharmacovigilance programme: a prospective cohort study. Drug Saf. 2017;40(5):409-18.
DOI
|
21 |
Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rissmann R, Kramers C, et al. Pharmacovigilance skills, knowledge and attitudes in our future doctors-A nationwide study in the Netherlands. Basic Clin Pharmacol. 2017;120(5):475-81.
DOI
|
22 |
Korea Institute of Drug Safety & Risk Management, Drug Safety Information. In: KIDS Webpage. [cited 2020 12 Jan]; Available from: https://www.drugsafe.or.kr/
|
23 |
Choi N-K, Kwon H-B, Lee A-Y, Park B-J. A Survey on Attitudes and Awareness of Physicians and Pharmacists Regarding Spontaneous Reporting System and Experience for Adverse Drug Events in Goyang-si. JPERM, 2008;1: 44-52.
|
24 |
Teong C-H, Jeong J-S, Park K-H, Lee D-W, Park S-C. Medical Staff's Attitude towards Adverse Drug Reaction in the Dongguk University Gyeongju Hospital. Korean J Fam Pract. 2015;5(1):25-33.
|
25 |
World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. 2004 [cited 2020 12 Jan]; Available from: https://apps.who.int/iris/bitstream/handle/10665/43034/9241592214_eng.pdf.
|
26 |
Wechwithan S, Suwankesawong W, Sornsrivichai V, McNeil EB, Jiraphongsa C, Chongsuvivatwong V. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk. Regul Toxicol Pharmacol. 2014;70(1):407-12.
DOI
|
27 |
Kim M, Han C-H. Analysis of Herbal-drug -associated Adverse Drug Reactions Using Data from Spontaneous Reporting System in Electronic Medical Records. J Korean Med. 2015;36(1):45-60.
DOI
|
28 |
Fahim SM, Mishuk AU, Cheng N, Hansen R, Calderon AI, Qian J. Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opin Drug Saf. 2019;18(2): 145-52.
DOI
|
29 |
Li H, Deng J, Yue Z, Zhang Y, Sun H. Detecting drug-herbal interaction using a spontaneous reporting system database: an example with benzylpenicillin and qingkailing injection. Eur J Clin Pharmacol. 2015;71(9):1139-45.
DOI
|
30 |
Kwon Y-J, Jo W-K, Han C-H. Status of Herbal-drug-associated Adverse Drug Reactions Voluntarily Reported by EMR. J Int Korean Med. 2012;33(4):485-97.
|
31 |
Lee SH, Song BW, Choi HJ, Kim EY. The Analysis of Herbal Medicine-Associated Adverse Drug Reactions Spontaneously Reported in a Korean Medicine Hospital. J Kor Soc Health-syst Pharm. 2017;34(2):183-99.
|
32 |
Cho J-H, Oh D-S, Hong S-H, Ko H, Lee N-H, Park S-E, et al. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol. 2017;91(12): 4009-15.
DOI
|
33 |
Kim M, Han C-H. Adverse drug reactions in Korean herbal medicine: A prospective cohort study. Eur J Integr Med. 2017;9:103-9.
DOI
|
34 |
Woo Y, Hyun MK. Safety of herbal medicine for elderly patients with chronic disease in the Republic of Korea. Eur J Integr Med. 2019;30:100934.
DOI
|
35 |
De Smet PA. An introduction to herbal pharmacoepidemiology. J Ethnopharmacol. 1993;38(2-3):189-95.
DOI
|
36 |
Elkalmi RM, Hassali MA, Ibrahim MIM, Widodo RT, Efan QMA, Hadi MA. Pharmacy Students' Knowledge and Perceptions About Pharmacovigilance in Malaysian Public Universities. Am J Pharm Educ. 2011;75(5):96.
DOI
|
37 |
Kim HJ, Hwang SY. Impact of Safety Climate Perception and Barriers to Adverse Drug Reaction Reporting on Clinical Nurses' Monitoring Practice for Adverse Drug Reactions. Korean J Adult Nurs. 2018;30(2):115-25.
DOI
|
38 |
Kyung EJ, Rew JH, Oh M, Kim EY. A Survey on Attitude and Awareness of Health-Care Professionals Regarding Pharmacovigilance System and Experience for Adverse Drug Reaction (ADR) from a Single University Hospital. Korean K Clin Pharm. 2013;23(3):256-68.
|
39 |
Farah M. Guidelines for herbal ATC classification. Uppsala Monitoring Centre. Uppsala. 2004.
|
40 |
Farah M. Herbal ATC index. Uppsala. Uppsala Monitoring Centre. 2004.
|
41 |
Uppsala Monitoring Center. What's New in WHODrug (March 1, 2018). [cited 2020 12 Jan]; Available from: https://www.who-umc.org/media/164170/whats-new-in-whodrug-2018.pdf.
|
42 |
ISoP, Herbal and Traditional Medicine Group. In: Special Interest Group. 2017 [cited 2020 12 Jan]; Available from: https://isoponline.org/special-interest-groups/herbal-and-traditional-medicines-2.
|
43 |
Ministry of Food and Drug Safety/Pusan University. Construction of Herbal Drug Code System for Pharmacovigilance. 2018 [cited 2020 12 Jan]; Available from: http://www.ndsl.kr/ndsl/search/detail/report/reportSearchResultDetail.do?cn=TRKO201900003538.
|
44 |
Lesar TS, Briceland L, Stein DS. Factors Related to Errors in Medication Prescribing. JAMA. 1997;277(4):312-7.
DOI
|
45 |
Reumerman M, Tichelaar J, Piersma B, Richir MC, van Agtmael MA. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235-48.
DOI
|
46 |
Gavaza P, Bui B. Pharmacy students' attitudes toward reporting serious adverse drug events. Am J Pharm Educ. 2012;76(10):194.
DOI
|
47 |
Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van Puijenbroek E. Effectiveness of pharmacovigilance training of General Practitioners. Drug Saf. 2011;34(9):755-62.
DOI
|